# Sequential Treatment of Pediatric MDD to Increase Remission and Prevent Relapse

> **NCT00612313** · NA · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 144 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** Fluoxetine
- **BEHAVIORAL:** Relapse prevention cognitive behavioral therapy (CBT)

## Key facts

- **NCT ID:** NCT00612313
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2013-02
- **Final completion:** 2014-01
- **Target enrollment:** 144 (ACTUAL)
- **Last updated:** 2016-01-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00612313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00612313, "Sequential Treatment of Pediatric MDD to Increase Remission and Prevent Relapse". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00612313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*